512 related articles for article (PubMed ID: 9360530)
1. Short-term modulation of the androgen milieu alters pulsatile, but not exercise- or growth hormone (GH)-releasing hormone-stimulated GH secretion in healthy men: impact of gonadal steroid and GH secretory changes on metabolic outcomes.
Fryburg DA; Weltman A; Jahn LA; Weltman JY; Samojlik E; Hintz RL; Veldhuis JD
J Clin Endocrinol Metab; 1997 Nov; 82(11):3710-9. PubMed ID: 9360530
[TBL] [Abstract][Full Text] [Related]
2. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
Gentili A; Mulligan T; Godschalk M; Clore J; Patrie J; Iranmanesh A; Veldhuis JD
J Clin Endocrinol Metab; 2002 Feb; 87(2):825-34. PubMed ID: 11836328
[TBL] [Abstract][Full Text] [Related]
3. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
[TBL] [Abstract][Full Text] [Related]
4. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
5. Determinants of GH-releasing hormone and GH-releasing peptide synergy in men.
Veldhuis JD; Bowers CY
Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1085-92. PubMed ID: 19240251
[TBL] [Abstract][Full Text] [Related]
6. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
[TBL] [Abstract][Full Text] [Related]
7. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
[TBL] [Abstract][Full Text] [Related]
8. Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone.
Giustina A; Scalvini T; Tassi C; Desenzani P; Poiesi C; Wehrenberg WB; Rogol AD; Veldhuis JD
J Clin Endocrinol Metab; 1997 Apr; 82(4):1210-9. PubMed ID: 9100598
[TBL] [Abstract][Full Text] [Related]
9. Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.
Veldhuis JD; Keenan DM; Bailey JN; Miles JM; Bowers CY
Eur J Endocrinol; 2009 Aug; 161(2):293-300. PubMed ID: 19458139
[TBL] [Abstract][Full Text] [Related]
10. Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men.
Bergendahl M; Aloi JA; Iranmanesh A; Mulligan TM; Veldhuis JD
J Clin Endocrinol Metab; 1998 Jun; 83(6):1967-75. PubMed ID: 9626127
[TBL] [Abstract][Full Text] [Related]
11. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study.
Juul A; Andersson AM; Pedersen SA; Jørgensen JO; Christiansen JS; Groome NP; Skakkebaek NE
Horm Res; 1998; 49(6):269-78. PubMed ID: 9623518
[TBL] [Abstract][Full Text] [Related]
12. Contrasting negative-feedback control of endogenously driven and exercise-stimulated pulsatile growth hormone secretion in women and men.
Veldhuis JD; Patrie J; Wideman L; Patterson M; Weltman JY; Weltman A
J Clin Endocrinol Metab; 2004 Feb; 89(2):840-6. PubMed ID: 14764803
[TBL] [Abstract][Full Text] [Related]
13. Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp.
Veldhuis JD; Keenan DM; Bailey JN; Adeniji AM; Miles JM; Bowers CY
J Clin Endocrinol Metab; 2009 Jun; 94(6):2137-43. PubMed ID: 19351723
[TBL] [Abstract][Full Text] [Related]
14. Effect of GH and/or testosterone deficiency on the prostate: an ultrasonographic and endocrine study in GH-deficient adult patients.
Colao A; Spiezia S; Di Somma C; Marzullo P; Cerbone G; Pivonello R; Faggiano A; Lombardi G
Eur J Endocrinol; 2000 Jul; 143(1):61-9. PubMed ID: 10870032
[TBL] [Abstract][Full Text] [Related]
15. Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man.
degli Uberti EC; Ambrosio MR; Cella SG; Margutti AR; Trasforini G; Rigamonti AE; Petrone E; Müller EE
J Clin Endocrinol Metab; 1997 Sep; 82(9):2885-8. PubMed ID: 9284714
[TBL] [Abstract][Full Text] [Related]
16. Short-term fasting suppresses leptin and (conversely) activates disorderly growth hormone secretion in midluteal phase women--a clinical research center study.
Bergendahl M; Evans WS; Pastor C; Patel A; Iranmanesh A; Veldhuis JD
J Clin Endocrinol Metab; 1999 Mar; 84(3):883-94. PubMed ID: 10084566
[TBL] [Abstract][Full Text] [Related]
17. Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay.
Veldhuis JD; Liem AY; South S; Weltman A; Weltman J; Clemmons DA; Abbott R; Mulligan T; Johnson ML; Pincus S
J Clin Endocrinol Metab; 1995 Nov; 80(11):3209-22. PubMed ID: 7593428
[TBL] [Abstract][Full Text] [Related]
18. Gonadal status and body mass index jointly determine growth hormone (GH)-releasing hormone/GH-releasing peptide synergy in healthy men.
Paulo RC; Cosma M; Soares-Welch C; Bailey JN; Mielke KL; Miles JM; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2008 Mar; 93(3):944-50. PubMed ID: 18073313
[TBL] [Abstract][Full Text] [Related]
19. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.
Iranmanesh A; South S; Liem AY; Clemmons D; Thorner MO; Weltman A; Veldhuis JD
Eur J Endocrinol; 1998 Jul; 139(1):59-71. PubMed ID: 9703380
[TBL] [Abstract][Full Text] [Related]
20. A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men.
Bhasin S; Swerdloff RS; Steiner B; Peterson MA; Meridores T; Galmirini M; Pandian MR; Goldberg R; Berman N
J Clin Endocrinol Metab; 1992 Jan; 74(1):75-83. PubMed ID: 1727832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
